Lingling Wu

1.7k total citations
65 papers, 1.2k citations indexed

About

Lingling Wu is a scholar working on Molecular Biology, Nephrology and Immunology. According to data from OpenAlex, Lingling Wu has authored 65 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 16 papers in Nephrology and 16 papers in Immunology. Recurrent topics in Lingling Wu's work include Renal Diseases and Glomerulopathies (9 papers), Chronic Kidney Disease and Diabetes (7 papers) and Renal and related cancers (7 papers). Lingling Wu is often cited by papers focused on Renal Diseases and Glomerulopathies (9 papers), Chronic Kidney Disease and Diabetes (7 papers) and Renal and related cancers (7 papers). Lingling Wu collaborates with scholars based in China, United States and Taiwan. Lingling Wu's co-authors include Xiangmei Chen, Guangyan Cai, Quan Hong, Zhe Feng, Bo Fu, Shaoyuan Cui, Wen Cao, Chao Hu, Jie Gao and Xiaoniao Chen and has published in prestigious journals such as PLoS ONE, Biomaterials and Cancer Research.

In The Last Decade

Lingling Wu

60 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingling Wu China 21 468 260 240 151 108 65 1.2k
Yuan Gui China 22 625 1.3× 269 1.0× 211 0.9× 107 0.7× 113 1.0× 52 1.3k
Chengguo Wei United States 18 453 1.0× 311 1.2× 174 0.7× 92 0.6× 92 0.9× 28 1.1k
Haimei Liu China 19 419 0.9× 209 0.8× 177 0.7× 86 0.6× 96 0.9× 100 1.2k
Jun Hao China 23 629 1.3× 264 1.0× 174 0.7× 159 1.1× 64 0.6× 57 1.3k
Zhigang Zhang China 17 717 1.5× 448 1.7× 173 0.7× 131 0.9× 104 1.0× 64 1.5k
Xuejing Zhu China 20 701 1.5× 478 1.8× 200 0.8× 267 1.8× 103 1.0× 34 1.5k
Ruizhi Tan China 21 716 1.5× 340 1.3× 188 0.8× 133 0.9× 149 1.4× 73 1.4k
José Luis Morgado‐Pascual Spain 14 478 1.0× 281 1.1× 165 0.7× 77 0.5× 71 0.7× 23 1.0k
Qiuling Fan China 21 622 1.3× 376 1.4× 142 0.6× 193 1.3× 73 0.7× 70 1.3k

Countries citing papers authored by Lingling Wu

Since Specialization
Citations

This map shows the geographic impact of Lingling Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingling Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingling Wu more than expected).

Fields of papers citing papers by Lingling Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingling Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingling Wu. The network helps show where Lingling Wu may publish in the future.

Co-authorship network of co-authors of Lingling Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Lingling Wu. A scholar is included among the top collaborators of Lingling Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingling Wu. Lingling Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Jian, Beibei Qiu, Wei­min Kong, et al.. (2025). Acute air pollution exposure and gastrointestinal cancer mortality: a case-crossover study in coastal China. Frontiers in Public Health. 13. 1666928–1666928. 1 indexed citations
2.
Chen, Yan, Gang Wu, Fulong Wang, et al.. (2025). Targeting the NLRP3 in macrophages contributes to senescence cell clearance in radiation-induced skin injury. Journal of Translational Medicine. 23(1). 196–196. 1 indexed citations
3.
Wu, Lingling, Long Chen, Huijuan Li, et al.. (2024). Nocardia rubra cell-wall skeleton mitigates whole abdominal irradiation-induced intestinal injury via regulating macrophage function. Burns & Trauma. 12. tkad045–tkad045. 1 indexed citations
5.
Chen, Yulan, Xueyuan Bai, Jianwen Chen, et al.. (2023). Pyruvate kinase M2 regulates kidney fibrosis through pericyte glycolysis during the progression from acute kidney injury to chronic kidney disease. Cell Proliferation. 57(2). e13548–e13548. 22 indexed citations
6.
Li, Xiaofan, Yiyao Deng, Jianwen Chen, et al.. (2023). The PI3K-Akt-mTOR pathway mediates renal pericyte-myofibroblast transition by enhancing glycolysis through HKII. Journal of Translational Medicine. 21(1). 323–323. 25 indexed citations
7.
Li, Chenchen, Lingling Wu, Yuan Guo, et al.. (2023). MicroRNA-668-3p inhibits myoblast proliferation and differentiation by targeting Appl1. BMC Genomics. 24(1). 415–415. 4 indexed citations
8.
Wu, Lingling, Zhaoyang Fan, Jincheng Liu, et al.. (2023). QiShenYiQi dripping pill alleviates myocardial ischemia-induced ferroptosis via improving mitochondrial dynamical homeostasis and biogenesis. Journal of Ethnopharmacology. 308. 116282–116282. 40 indexed citations
9.
Chen, Wanchao, Yang Wang, Jiancheng Zheng, et al.. (2023). Characterization of cellular senescence in radiation ulcers and therapeutic effects of mesenchymal stem cell-derived conditioned medium. Burns & Trauma. 11. tkad001–tkad001. 16 indexed citations
10.
Peng, Fei, Lingling Wu, Jie Wu, et al.. (2023). Serum levels of sonic hedgehog in patients with IgA nephropathy are closely associated with intrarenal arteriolar lesions. Clinical Biochemistry. 123. 110687–110687.
11.
Liu, Fei, Zixian Wang, Xiaofan Li, et al.. (2022). Comparative risk of acute kidney injury among cancer patients treated with immune checkpoint inhibitors. Cancer Communications. 43(2). 214–224. 9 indexed citations
12.
Chen, Huijuan, Hong Wang, Lijuan Qiu, et al.. (2022). Relation Among Anxiety, Depression, Sleep Quality and Health-Related Quality of Life Among Patients with Systemic Lupus Erythematosus: Path Analysis. Patient Preference and Adherence. Volume 16. 1351–1358. 7 indexed citations
13.
Cui, Shaoyuan, Quan Hong, Wanjun Shen, et al.. (2022). Role of NOD-Like Receptors in a Miniature Pig Model of Diabetic Renal Injuries. Mediators of Inflammation. 2022. 1–9. 4 indexed citations
14.
Wu, Lingling, Li Ou, Xu Wang, et al.. (2021). Krϋppel‐like factor 15 suppresses renal glomerular mesangial cell proliferation via enhancing P53 SUMO1 conjugation. Journal of Cellular and Molecular Medicine. 25(12). 5691–5706. 8 indexed citations
15.
Zhao, Yinghua, Bo Fu, Pu Chen, et al.. (2021). Activated mesangial cells induce glomerular endothelial cells proliferation in rat anti‐Thy‐1 nephritis through VEGFA/VEGFR2 and Angpt2/Tie2 pathway. Cell Proliferation. 54(6). e13055–e13055. 18 indexed citations
16.
Zhao, Yinghua, Qinggang Li, Qing Ouyang, Lingling Wu, & Xiangmei Chen. (2020). Activated mesangial cells acquire the function of antigen presentation. Cellular Immunology. 361. 104279–104279. 14 indexed citations
17.
Bai, Jiuxu, Lingling Wu, Xiaoniao Chen, et al.. (2018). Suppressor of Cytokine Signaling-1/STAT1 Regulates Renal Inflammation in Mesangial Proliferative Glomerulonephritis Models. Frontiers in Immunology. 9. 1982–1982. 19 indexed citations
18.
Yao, Ling, Lingling Wu, Qian Li, et al.. (2018). Novel berberine derivatives: Design, synthesis, antimicrobial effects, and molecular docking studies. Chinese Journal of Natural Medicines. 16(10). 774–781. 15 indexed citations
19.
Chang, Wenjun, Lingling Wu, Fuao Cao, et al.. (2011). Development of Autoantibody Signatures as Biomarkers for Early Detection of Colorectal Carcinoma. Clinical Cancer Research. 17(17). 5715–5724. 27 indexed citations
20.
Wang, Yaolin, Xiaoying Wang, Philip Lipari, et al.. (2008). SCH 727965, a novel cyclin-dependent kinase inhibitor, has potent anti-tumor acitivity in a wide-spectrum of human tumor xenograft models. Cancer Research. 68. 1594–1594. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026